Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1993 Jul;37(7):1452–1455. doi: 10.1128/aac.37.7.1452

Evaluation of bacterial interference and beta-lactamase production in management of experimental infection with group A beta-hemolytic streptococci.

I Brook 1, J D Gilmore 1
PMCID: PMC187993  PMID: 8363375

Abstract

The in vivo effects of penicillin and cefprozil therapy on the interaction between organisms commonly recovered from inflamed tonsils were studied by using a subcutaneous abscess model in mice. These organisms were group A beta-hemolytic streptococci (GABHS), Streptococcus salivarius (which is capable of interfering with GABHS), and Staphylococcus aureus. In mice infected with GABHS and S. salivarius alone or in combination, penicillin eliminated both organisms and cefprozil eliminated GABHS and S. aureus but not S. salivarius. Penicillin did not, however, reduce the number of GABHS or S. salivarius in the presence of S. aureus. The present study demonstrated the ability of beta-lactamase-producing S. aureus to protect GABHS from penicillin. However, no such protection was present following the administration of cefprozil. Furthermore, the preservation of S. salivarius that interferes with GABHS growth may provide protection from reinfection with GABHS. This study supports and provides an explanation for the increased efficacies of cephalosporins administered orally over that of penicillin when treating patients with acute GABHS pharyngitis or tonsillitis.

Full text

PDF
1452

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brook I., Hirokawa R. Treatment of patients with a history of recurrent tonsillitis due to group A beta-hemolytic streptococci. A prospective randomized study comparing penicillin, erythromycin, and clindamycin. Clin Pediatr (Phila) 1985 Jun;24(6):331–336. doi: 10.1177/000992288502400606. [DOI] [PubMed] [Google Scholar]
  2. Brook I. The role of beta-lactamase-producing bacteria in the persistence of streptococcal tonsillar infection. Rev Infect Dis. 1984 Sep-Oct;6(5):601–607. doi: 10.1093/clinids/6.5.601. [DOI] [PubMed] [Google Scholar]
  3. Brook I., Yocum P., Friedman E. M. Aerobic and anaerobic bacteria in tonsils of children with recurrent tonsillitis. Ann Otol Rhinol Laryngol. 1981 May-Jun;90(3 Pt 1):261–263. doi: 10.1177/000348948109000313. [DOI] [PubMed] [Google Scholar]
  4. Brook I., Yocum P. Quantitative measurement of beta lactamase in tonsils of children with recurrent tonsillitis. Acta Otolaryngol. 1984 Nov-Dec;98(5-6):556–559. doi: 10.3109/00016488409107597. [DOI] [PubMed] [Google Scholar]
  5. Brook I., Yokum P. In vitro protection of group A beta-hemolytic streptococci from penicillin and cephalothin by Bacteroides fragilis. Chemotherapy. 1983;29(1):18–23. doi: 10.1159/000238168. [DOI] [PubMed] [Google Scholar]
  6. Crowe C. C., Sanders W. E., Jr, Longley S. Bacterial interference. II. Role of the normal throat flora in prevention of colonization by group A Streptococcus. J Infect Dis. 1973 Oct;128(4):527–532. doi: 10.1093/infdis/128.4.527. [DOI] [PubMed] [Google Scholar]
  7. Gastanaduy A. S., Kaplan E. L., Huwe B. B., McKay C., Wannamaker L. W. Failure of penicillin to eradicate group A streptococci during an outbreak of pharyngitis. Lancet. 1980 Sep 6;2(8193):498–502. doi: 10.1016/s0140-6736(80)91832-2. [DOI] [PubMed] [Google Scholar]
  8. Grahn E., Holm S. E. Bacterial interference in the throat flora during a streptococcal tonsillitis outbreak in an apartment house area. Zentralbl Bakteriol Mikrobiol Hyg A. 1983 Nov;256(1):72–79. [PubMed] [Google Scholar]
  9. Hackman A. S., Wilkins T. D. In vivo protection of Fusobacterium necrophorum from penicillin by Bacteroides fragilis. Antimicrob Agents Chemother. 1975 May;7(5):698–703. doi: 10.1128/aac.7.5.698. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Jones R. N., Barry A. L. BMY-28100, a new oral cephalosporin: antimicrobial activity against nearly 7,000 recent clinical isolates, comparative potency with other oral agents, and activity against beta-lactamase producing isolates. Diagn Microbiol Infect Dis. 1988 Jan;9(1):11–26. doi: 10.1016/0732-8893(88)90056-9. [DOI] [PubMed] [Google Scholar]
  11. Kaplan E. L., Johnson D. R. Eradication of group A streptococci from the upper respiratory tract by amoxicillin with clavulanate after oral penicillin V treatment failure. J Pediatr. 1988 Aug;113(2):400–403. doi: 10.1016/s0022-3476(88)80291-9. [DOI] [PubMed] [Google Scholar]
  12. Marcon M. J., Hribar M. M., Hosier D. M., Powell D. A., Brady M. T., Hamoudi A. C., Kaplan E. L. Occurrence of mucoid M-18 Streptococcus pyogenes in a central Ohio pediatric population. J Clin Microbiol. 1988 Aug;26(8):1539–1542. doi: 10.1128/jcm.26.8.1539-1542.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Neu H. C. Antibacterial therapy: problems and promises, Part I. Hosp Pract (Off Ed) 1990 May 15;25(5):63-74, 77-8. doi: 10.1080/21548331.1990.11703947. [DOI] [PubMed] [Google Scholar]
  14. O'Callaghan C. H., Morris A., Kirby S. M., Shingler A. H. Novel method for detection of beta-lactamases by using a chromogenic cephalosporin substrate. Antimicrob Agents Chemother. 1972 Apr;1(4):283–288. doi: 10.1128/aac.1.4.283. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Pichichero M. E., Margolis P. A. A comparison of cephalosporins and penicillins in the treatment of group A beta-hemolytic streptococcal pharyngitis: a meta-analysis supporting the concept of microbial copathogenicity. Pediatr Infect Dis J. 1991 Apr;10(4):275–281. doi: 10.1097/00006454-199104000-00002. [DOI] [PubMed] [Google Scholar]
  16. Reilly S., Timmis P., Beeden A. G., Willis A. T. Possible role of the anaerobe in tonsillitis. J Clin Pathol. 1981 May;34(5):542–547. doi: 10.1136/jcp.34.5.542. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Roos K., Grahn E., Holm S. E. Evaluation of beta-lactamase activity and microbial interference in treatment failures of acute streptococcal tonsillitis. Scand J Infect Dis. 1986;18(4):313–319. doi: 10.3109/00365548609032342. [DOI] [PubMed] [Google Scholar]
  18. SIMON H. J., SAKAI W. Staphylococcal antagonism to penicillin-G therapy of hemolytic streptococcal pharyngeal infection. Effect of oxacillin. Pediatrics. 1963 Mar;31:463–469. [PubMed] [Google Scholar]
  19. Scheifele D. W., Fussell S. J. Frequency of ampicillin-resistant Haemophilus parainfluenzae in children. J Infect Dis. 1981 Mar;143(3):495–498. doi: 10.1093/infdis/143.3.495. [DOI] [PubMed] [Google Scholar]
  20. Tunér K., Nord C. E. Betalactamase-producing microorganisms in recurrent tonsillitis. Scand J Infect Dis Suppl. 1983;39:83–85. [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES